WEBINAR | The ART of Japanese Market Entry: Navigating Japan's Pharmaceutical Landscape
Japan remains the world’s third-largest pharmaceutical market, but success requires a fundamentally different approach. Here, our Japan-based experts introduce the ART framework—Asset, Resource and Timeline—a practical lens for planning and executing a successful Japan market entry strategy.
In this webinar, we explore:
• Maximizing asset value within Japan’s pricing and reimbursement system
• Selecting the right Go-to-Market and partnership model for your stage and strategy
• Aligning regulatory, organizational and commercial milestones across a proven 24–36 month roadmap
Drawing on decades of hands-on experience supporting companies entering Japan, our speakers will share lessons learned, common pitfalls to avoid and practical guidance you can apply immediately.
Watch the replay and find more global commercialization content below.
Related Content
Looking for exclusive insight?
